EA200870352A1 - LIQUID COMPOSITIONS AND METHODS FOR INCREASING FABRIC - Google Patents

LIQUID COMPOSITIONS AND METHODS FOR INCREASING FABRIC

Info

Publication number
EA200870352A1
EA200870352A1 EA200870352A EA200870352A EA200870352A1 EA 200870352 A1 EA200870352 A1 EA 200870352A1 EA 200870352 A EA200870352 A EA 200870352A EA 200870352 A EA200870352 A EA 200870352A EA 200870352 A1 EA200870352 A1 EA 200870352A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
liquid compositions
increasing fabric
hydrogel
influence
Prior art date
Application number
EA200870352A
Other languages
Russian (ru)
Inventor
Натаниэль Е. Дэвид
Original Assignee
Китера Байофармасьютикалс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Китера Байофармасьютикалс, Инк. filed Critical Китера Байофармасьютикалс, Инк.
Publication of EA200870352A1 publication Critical patent/EA200870352A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light

Abstract

Композиции и способы для увеличения ткани после доставки к ограниченной области. Композиции включают гидрогель и кожный наполнитель. Гидрогель может полимеризовываться и/или образовывать поперечные связи под воздействием первого инициирующего фактора. Кожный наполнитель может также образовывать поперечные связи под воздействием второго инициирующего фактора.Compositions and methods for tissue enlargement after delivery to a limited area. Compositions include a hydrogel and a dermal filler. The hydrogel may polymerize and / or crosslink under the influence of the first initiating factor. The dermal filler may also form transverse bonds under the influence of a second initiating factor.

EA200870352A 2006-03-13 2007-03-12 LIQUID COMPOSITIONS AND METHODS FOR INCREASING FABRIC EA200870352A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/276,759 US20070212385A1 (en) 2006-03-13 2006-03-13 Fluidic Tissue Augmentation Compositions and Methods
PCT/US2007/006258 WO2007106457A2 (en) 2006-03-13 2007-03-12 Fluidic tissue augmentation compositions and methods

Publications (1)

Publication Number Publication Date
EA200870352A1 true EA200870352A1 (en) 2009-04-28

Family

ID=38479221

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870352A EA200870352A1 (en) 2006-03-13 2007-03-12 LIQUID COMPOSITIONS AND METHODS FOR INCREASING FABRIC

Country Status (11)

Country Link
US (4) US20070212385A1 (en)
EP (1) EP1996137A4 (en)
JP (1) JP2009529965A (en)
KR (1) KR20080109774A (en)
CN (1) CN101400327A (en)
AU (1) AU2007225196A1 (en)
BR (1) BRPI0708872A2 (en)
CA (1) CA2644561A1 (en)
EA (1) EA200870352A1 (en)
NO (1) NO20084124L (en)
WO (1) WO2007106457A2 (en)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666588B2 (en) * 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
FR2850282B1 (en) 2003-01-27 2007-04-06 Jerome Asius INJECTABLE IMPLANT BASED ON CERAMIC FOR THE FILLING OF WRINKLES, CUTANEOUS DEPRESSIONS AND SCARS, AND ITS PREPARATION
FR2861734B1 (en) 2003-04-10 2006-04-14 Corneal Ind CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
EP2152743A2 (en) 2007-05-23 2010-02-17 Allergan, Inc. Cross-linked collagen and uses thereof
ES2451441T3 (en) 2007-07-27 2014-03-27 Humacyte, Inc. Compositions comprising human collagen and human elastin and uses thereof
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
WO2009018546A1 (en) * 2007-08-02 2009-02-05 Medicis Pharmaceutical Corporation Method of applying an injectable filler
US20090204101A1 (en) * 2007-08-20 2009-08-13 Wortzman Mitchell S Method of applying an injectable filler
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US8709395B2 (en) 2007-10-29 2014-04-29 Ayman Boutros Method for repairing or replacing damaged tissue
US8431141B2 (en) * 2007-10-29 2013-04-30 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US7910134B2 (en) * 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8475815B2 (en) * 2007-10-29 2013-07-02 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
EP2217251A4 (en) * 2007-11-02 2010-11-10 Genzyme Corp Methods of augmenting or repairing soft tissue
JP5670196B2 (en) 2007-11-16 2015-02-18 バイセプト セラピューティクス、インク． Compositions and methods for treating purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8846003B2 (en) 2008-03-27 2014-09-30 Symic Biomedical, Inc. Collagen-binding synthetic peptidoglycans, preparation, and methods of use
GB2459438B (en) * 2008-04-10 2010-10-06 Kythera Biopharmaceuticals Inc Systems and methods for transdermal photo-polymerization
KR20110037979A (en) 2008-05-30 2011-04-13 알러간, 인코포레이티드 Injection device for soft-tissue augmentation fillers, bioactive agents and other biocompatible materials in liquid or gel form
US20110182957A1 (en) * 2008-06-19 2011-07-28 Nicoll Steven B Cellulosics for tissue replacement
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
ES2829971T3 (en) 2008-09-02 2021-06-02 Tautona Group Lp Hyaluronic acid threads and / or derivatives thereof, methods to manufacture them and uses thereof
JP5702723B2 (en) 2008-09-04 2015-04-15 ザ ジェネラル ホスピタル コーポレイション Hydrogels for strengthening and repairing vocal cords and soft tissues
CN102164580A (en) * 2008-09-16 2011-08-24 恩伟绅技术公司 Decomposable biocompatible hydrogels and system and method for using same
WO2010056899A1 (en) 2008-11-12 2010-05-20 The Trustees Of The University Of Pennsylvania Biomaterials for tissue replacement
EP3698831A1 (en) * 2008-12-02 2020-08-26 Allergan, Inc. Needle assembly and injection device
EP2432495B1 (en) * 2009-05-20 2017-03-22 Humacyte, Inc. Elastin for soft tissue augmentation
US20110137260A1 (en) 2009-12-07 2011-06-09 Allergan, Inc. Slotted syringe
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US9198568B2 (en) 2010-03-04 2015-12-01 The General Hospital Corporation Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production
FR2957254B1 (en) 2010-03-12 2016-10-14 Allergan Ind Sas FLUID COMPOSITIONS FOR IMPROVING SKIN CONDITIONS
PL2550027T5 (en) 2010-03-22 2019-07-31 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8815228B2 (en) 2010-04-30 2014-08-26 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
WO2011146713A1 (en) 2010-05-19 2011-11-24 Allergan, Inc. Modular injection device
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
GB201014388D0 (en) * 2010-08-31 2010-10-13 Fujifilm Mfg Europe Bv Biocompatible compositions for tissue augmentation
WO2012031245A1 (en) * 2010-09-03 2012-03-08 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
US20120130490A1 (en) * 2010-09-24 2012-05-24 Dominique Erni Method for reconstruction and augmentation of the breast
BR112013015482B1 (en) 2010-12-20 2018-04-17 L'oreal STERILE NET COMPOSITION DEDICATED TO ADMINISTRATION IN OR THROUGH SKIN AND / OR LIPS
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
MX349693B (en) 2011-05-24 2017-08-09 Symic Ip Llc Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use.
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
CN107412002A (en) 2011-06-03 2017-12-01 阿勒根公司 Dermal filler composition including antioxidant
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
CN102321248B (en) * 2011-06-10 2013-04-24 冯淑芹 Injectable temperature sensitive gel used for filling and repairing damaged tissues
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US9272079B2 (en) * 2011-10-13 2016-03-01 Kci Licensing, Inc. Stimulation of cartilage formation using reduced pressure treatment
US8603028B2 (en) 2011-11-18 2013-12-10 Allergan, Inc. Injection device having an angled tip portion
KR101269423B1 (en) * 2011-12-22 2013-05-30 오스템임플란트 주식회사 Hydrogel with controllable biodegradation behavior and the manufacturing method thereof
WO2014028463A1 (en) 2012-08-14 2014-02-20 Allergan, Inc. Syringe for mixing and dispensing adipose tissue
US9220807B2 (en) 2012-11-04 2015-12-29 Miba Medical Inc. Non-toxic cross-linker for hyaluronic acid
JP6441825B2 (en) 2013-02-28 2018-12-19 アモーレパシフィック コーポレーションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ Composition for maintaining efficacy of filler
SG11201506966RA (en) 2013-03-15 2015-10-29 Symic Biomedical Inc Extracellular matrix-binding synthetic peptidoglycans
US9744260B2 (en) 2013-04-12 2017-08-29 Phi Nguyen Timing controlled in-situ cross-linking of halyuronic acid during injection
US20150190517A1 (en) * 2013-04-12 2015-07-09 Miba Medical Inc. Systems and methods for delivering cross-linked halyuronic acid into a patient
WO2014169299A1 (en) * 2013-04-12 2014-10-16 Bui The Duy Temperature-release catalyst for cross-linking halyuronic acid during injection
US20140350516A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Mechanical syringe accessory
US20140350518A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Syringe extrusion accessory
WO2015084972A1 (en) * 2013-12-03 2015-06-11 Cornell University Method of repairing an annulus and collagen gel composition
WO2015141978A1 (en) * 2014-03-20 2015-09-24 (주)아모레퍼시픽 Composition for maintaining efficacy of filler
KR20150110332A (en) * 2014-03-20 2015-10-02 (주)아모레퍼시픽 Composition for maintaining effect of filler
BR112016023858A2 (en) * 2014-04-14 2017-08-15 Akina Inc An Indiana Us Corp hydrogel tissue dilators
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US9561095B1 (en) * 2015-10-12 2017-02-07 Phi Nguyen Body augmentation device
US10029048B2 (en) 2014-05-13 2018-07-24 Allergan, Inc. High force injection devices
AU2015289474B2 (en) 2014-07-17 2019-12-05 The Regents Of The University Of California Controllable self-annealing microgel particles for biomedical applications
US10722444B2 (en) 2014-09-30 2020-07-28 Allergan Industrie, Sas Stable hydrogel compositions including additives
US10226585B2 (en) 2014-10-01 2019-03-12 Allergan, Inc. Devices for injection and dosing
US9439983B1 (en) * 2014-10-24 2016-09-13 Verily Life Sciences Llc Method for integrating nanoparticles as part of a hydrogel matrix
TWI716365B (en) * 2014-11-13 2021-01-21 德商梅茲製藥有限兩合公司 Injectable dermal filler composition, a kit comprising the same, a method for preparing the same, and a use thereof
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
US10433928B2 (en) 2015-03-10 2019-10-08 Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company Multiple needle injector
CN104940998A (en) * 2015-06-08 2015-09-30 苏州乔纳森新材料科技有限公司 Soft tissue filling material and preparation method thereof
EP3868416B1 (en) * 2015-09-09 2022-08-10 ETH Zurich Injectable macroporous hydrogels
EP3355968B1 (en) * 2015-10-02 2021-05-12 F. Hoffmann-La Roche AG Multi chamber syringe unit
US20170103184A1 (en) * 2015-10-12 2017-04-13 Phi Nguyen Injectable filler
US10112119B2 (en) * 2015-11-09 2018-10-30 Disney Enterprises, Inc. Method for modifying local properties of materials
US11931480B2 (en) 2016-02-16 2024-03-19 The Regents Of The University Of California Microporous annealed particle gels and methods of use
KR102288170B1 (en) 2016-04-08 2021-08-09 알레간 인코포레이티드 Aspiration and injection device
KR101710639B1 (en) * 2016-06-07 2017-03-08 주식회사 파마리서치프로덕트 Filler composition comprising nucleic acid, chitosan and hyaluronic acid for tissue augmentation and process for producing the same
KR20180035032A (en) * 2016-09-28 2018-04-05 주식회사 파마리서치프로덕트 Injectable composition comprising cross-linked hyaluronic acid
AU2017394923B2 (en) 2016-12-29 2022-07-14 Tempo Therapeutics, Inc. Methods and systems for treating a site of a medical implant
USD867582S1 (en) 2017-03-24 2019-11-19 Allergan, Inc. Syringe device
US20180368394A1 (en) * 2017-06-27 2018-12-27 Inteli-Straw, LLC Semen/gamete and embryo storage receptacles with rfid data identification
WO2019010484A2 (en) 2017-07-07 2019-01-10 Symic Ip, Llc Synthetic bioconjugates
KR102008667B1 (en) 2017-11-02 2019-08-08 주식회사 엑소코바이오 Filler composition of stabilized exosome
KR20190051434A (en) 2017-11-07 2019-05-15 주식회사 엑소코바이오 New filler composition based on hyaluronic acid and its application
CN109651625A (en) * 2018-12-17 2019-04-19 北京理工大学 A kind of preparation method of high strength acrylic amide-carboxymethyl cellulose dual network constitution water gel smother pad
CN110575564B (en) * 2019-09-30 2020-05-08 张勇 Filler for medical plastic cosmetology and preparation method and application thereof
US20230263943A1 (en) * 2020-04-29 2023-08-24 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels for in situ-forming tissue constructs
WO2022031073A1 (en) * 2020-08-06 2022-02-10 주식회사 삼양홀딩스 Composition for hydrogel formation, hydrogel formed by photo-crosslinking same, and method for preparing hydrogel
CN114146021A (en) * 2021-12-31 2022-03-08 北京清美联创干细胞科技有限公司 Cosmetic composition containing epidermal growth factor and preparation method thereof

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380536A (en) * 1978-04-06 1983-04-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing para-amino-benzoic acid-N-D-mannoside as an active ingredient
US4645969A (en) * 1980-08-01 1987-02-24 General Electric Company Skin tanning fluorescent lamp construction utilizing a phosphor combination
US5024742A (en) * 1988-02-24 1991-06-18 Cedars-Sinai Medical Center Method of crosslinking amino acid containing polymers using photoactivatable chemical crosslinkers
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5529914A (en) * 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
US5380536A (en) * 1990-10-15 1995-01-10 The Board Of Regents, The University Of Texas System Biocompatible microcapsules
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
EP0696185B1 (en) * 1993-04-28 1998-08-12 Focal, Inc. Apparatus, product and use related to intraluminal photothermoforming
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
US5964749A (en) * 1995-09-15 1999-10-12 Esc Medical Systems Ltd. Method and apparatus for skin rejuvenation and wrinkle smoothing
US7883693B2 (en) * 1995-12-18 2011-02-08 Angiodevice International Gmbh Compositions and systems for forming crosslinked biomaterials and methods of preparation of use
US5902599A (en) * 1996-02-20 1999-05-11 Massachusetts Institute Of Technology Biodegradable polymer networks for use in orthopedic and dental applications
US6106514A (en) * 1996-08-12 2000-08-22 O'donnell, Jr.; Francis E. Laser method for subsurface cutaneous treatment
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
US6162211A (en) * 1996-12-05 2000-12-19 Thermolase Corporation Skin enhancement using laser light
US6224893B1 (en) * 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US6165205A (en) * 1998-07-10 2000-12-26 Ceramoptec Industries, Inc. Method for improved wound healing
US6663659B2 (en) * 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6231613B1 (en) * 1998-12-15 2001-05-15 Enteric Medical Technologies, Inc. Methods for soft tissue augmentation in mammals
US6858229B1 (en) * 1999-04-26 2005-02-22 California Institute Of Technology In situ forming hydrogels
US6333029B1 (en) * 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US20020128695A1 (en) * 1999-07-07 2002-09-12 Yoram Harth Apparatus and method for high energy photodynamic therapy of acne vulgaris and seborrhea
US20020088131A1 (en) * 1999-10-08 2002-07-11 Baxa Ronald Dale Syringe dose identification system
US6699470B1 (en) * 1999-10-12 2004-03-02 Massachusetts Institute Of Technology Mesh-gel constructs for cell delivery containing enzymes and/or enzyme inhibitors to control gel degradation
DK1103232T3 (en) * 1999-11-29 2005-01-10 Mectron S R L Dental handpiece for polymerizing photo-curing compounds or resins compatible with the energy supply of other handpieces
US6527764B1 (en) * 1999-12-02 2003-03-04 Ceramoptec Industries, Inc. Device and method for laser biomodulation in PDT/surgery
US7097855B1 (en) * 2000-01-31 2006-08-29 Massachusetts Institute Of Technology Transdermal thermal polymerization
CA2427543A1 (en) * 2000-03-15 2004-11-02 Yu-Ling Cheng Thermally reversible implant and filler
EP2269645A3 (en) * 2000-08-16 2011-01-12 The General Hospital Corporation doing business as Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
US6602275B1 (en) * 2000-09-18 2003-08-05 Jana Sullivan Device and method for therapeutic treatment of living organisms
US6773713B2 (en) * 2001-02-23 2004-08-10 University Of Massachusetts Injection molding of living tissues
US20030009158A1 (en) * 2001-07-09 2003-01-09 Perricone Nicholas V. Skin treatments using blue and violet light
US6835064B2 (en) * 2001-11-09 2004-12-28 Ivoclar Vivadent Ag Light hardening device and method for hardening a polymerizable mass for dental applications
EP1314402B1 (en) * 2001-11-22 2005-06-29 Mectron S.R.L. Optical system for a dental Handpiece for polymerization of photosetting compounds or resins
US6843967B2 (en) * 2002-04-11 2005-01-18 Pentron Laboratory Technologies, Llc Curing unit
US7113950B2 (en) * 2002-06-27 2006-09-26 Microsoft Corporation Automated error checking system and method
US8673333B2 (en) * 2002-09-25 2014-03-18 The Johns Hopkins University Cross-linked polymer matrices, and methods of making and using same
US7862831B2 (en) * 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US20050069572A1 (en) * 2002-10-09 2005-03-31 Jennifer Elisseeff Multi-layered polymerizing hydrogels for tissue regeneration
JP2004284820A (en) * 2002-12-10 2004-10-14 Inventio Ag Device for sealing a gap between car door and car wall in elevator car
AU2003207356A1 (en) * 2003-02-26 2004-09-17 Photo Therapeutics Ltd. Therapeutic method and apparatus
EP1610674A4 (en) * 2003-03-13 2008-05-21 Cheryl M Burgess Methods of administering a material into a patient for dermal enhancement
US20060222677A1 (en) * 2004-01-14 2006-10-05 Bianca Baroli Method of protecting sensitive molecules from a photo-polymerizing environment
WO2005105172A1 (en) * 2004-04-20 2005-11-10 Genzyme Corporation Surgical mesh-like implant
JP2008502690A (en) * 2004-06-15 2008-01-31 アンドリュー シァン チェン， Phospholipid composition and methods for its preparation and use
EP1796690A4 (en) * 2004-09-22 2011-08-03 Cartilix Inc Cartilage filling device
US7414021B2 (en) * 2004-10-01 2008-08-19 Vincent Carmine Giampapa Method and composition for restoration of age related tissue loss in the face or selected areas of the body
CA2585215A1 (en) * 2004-10-28 2006-05-11 Surmodics, Inc. Pro-fibrotic coatings comprising collagen for medical implants
EP1843798A2 (en) * 2005-01-27 2007-10-17 Corium International Inc., Hydrophylic biocompatible adhesive formulations and uses
US7321004B2 (en) * 2005-02-11 2008-01-22 New Photonics, Llc Method for photo-curing polymerizable compositions
US20060188940A1 (en) * 2005-02-22 2006-08-24 Michael Cima Combinatorial hydrogel formulation
WO2006138542A2 (en) * 2005-06-15 2006-12-28 Surmodics, Inc. Macromer composition including light activated initiator
CA2610592A1 (en) * 2005-06-16 2006-12-28 Artes Medical, Inc. Liquid crystal polymer syringes and containers and methods of use for long term storage of filler materials
WO2007002664A2 (en) * 2005-06-22 2007-01-04 Massachusetts Institute Of Technology Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel
US7521434B2 (en) * 2005-06-27 2009-04-21 Luromed Llc Cross-linked gels of hyaluronic acid with hydrophobic polymers and processes for making them
US8999933B2 (en) * 2006-01-18 2015-04-07 Biolitec Pharma Marketing Ltd Photodynamic cosmetic procedure and healing method
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
TWI291417B (en) * 2006-08-10 2007-12-21 Hi Touch Imaging Tech Co Ltd Printer having a printhead with fixed angle
EP2217251A4 (en) * 2007-11-02 2010-11-10 Genzyme Corp Methods of augmenting or repairing soft tissue
GB2459438B (en) * 2008-04-10 2010-10-06 Kythera Biopharmaceuticals Inc Systems and methods for transdermal photo-polymerization

Also Published As

Publication number Publication date
US20110087152A1 (en) 2011-04-14
WO2007106457A2 (en) 2007-09-20
US20070212385A1 (en) 2007-09-13
AU2007225196A1 (en) 2007-09-20
WO2007106457A3 (en) 2007-11-29
US20080038306A1 (en) 2008-02-14
NO20084124L (en) 2008-12-03
EP1996137A4 (en) 2012-06-20
BRPI0708872A2 (en) 2011-06-14
JP2009529965A (en) 2009-08-27
CA2644561A1 (en) 2007-09-20
US20160279288A1 (en) 2016-09-29
CN101400327A (en) 2009-04-01
EP1996137A2 (en) 2008-12-03
KR20080109774A (en) 2008-12-17

Similar Documents

Publication Publication Date Title
EA200870352A1 (en) LIQUID COMPOSITIONS AND METHODS FOR INCREASING FABRIC
CY1119616T1 (en) HUMAN ANTI-DUMP DRUG CONSUMPTION AGAINST TISSUE
CL2016003014A1 (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) (divisional sol. No. 230-11).
EP3219725A3 (en) Dkk1 antibodies and methods of use
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
EA201001223A1 (en) STABILIZED PROTEIN COMPOSITIONS
EA201001529A1 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF MIF-MEDIATED DISORDERS
EA201390803A1 (en) Bromodomain inhibitors and their use
CR20110091A (en) NEUTRALIZING ANTIBODIES OF HUMAN CITOMEGALOVIRUS AND USE OF THE SAME
EA201370066A1 (en) MODULATORS OF ESTROGEN RECEPTORS AND THEIR APPLICATION
MA32161B1 (en) Rifaximin forms and uses thereof
CR20110470A (en) PROTEINS OF UNION TO IL-17
WO2010065954A3 (en) Sparc binding peptides and uses thereof
CL2008001114A1 (en) Compounds derived from benzimidazole; pharmaceutical composition; and use in the treatment of diseases such as overactive bladder, pain, obesity, seizures, among others.
GT200800250A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
NZ725131A (en) Tubulysin derivatives
CL2008001373A1 (en) Compounds derived from substituted phenylamino-benzene; Preparation method; pharmaceutical composition; farm kit; and use of said compounds in the treatment of cancer.
PE20140190A1 (en) NOTUM PROTEIN MODULATORS AND METHODS OF USE
GB2460597A (en) N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
BRPI0912292A2 (en) compositions and methods for the use of cells in the treatment of cardiac tissue.
CR20120579A (en) CONJUGATED FACTOR VIII FOR BLOOD COAGULATION
EA201190295A1 (en) COMPOSITIONS FOR DERMAL DELIVERY CONTAINING COMPLEXES OF THE ACTIVE AGENT WITH PARTICLES OF CALCIUM PHOSPHATE AND METHODS OF THEIR APPLICATION
EA201290941A1 (en) CONJUGATED BLOOD COAGULATION FACTOR VIIa
CL2007002689A1 (en) COMPOUNDS DERIVED FROM PIPERIDIN-1-CARBOXAMIDA, INHIBITORS OF THE RENINE; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS HYPERTENSION, CARDIAC INSUFFICIENCY, CARDIAC FIBROSIS, AMONG OTHERS.
UY34785A (en) FORMULATION IN SOLUBILIZED CAPSULES OF [(1S) -1 - {[(2S, 4R) -4- (7-CHLORO-4METOXIISOQUINOLIN-1-ILOXI) -2 - ({(1R, 2S) -1 - [(CICLOPROPILSULFONIL) CARBAMOIL] -2-ETHYL-CYCLOPROPIL} CARBAMOIL) PIRROLIDIN-1-IL] CARBONIL} -2,2-DIMETHYLPROPYL] 1,1-DIMETHYLL CARBAMATE